BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 20890217)

  • 1. Hepatic progenitor cell proliferation and liver injury in α-1-antitrypsin deficiency.
    Brunt EM; Blomenkamp K; Ahmed M; Ali F; Marcus N; Teckman J
    J Pediatr Gastroenterol Nutr; 2010 Nov; 51(5):626-30. PubMed ID: 20890217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indomethacin increases liver damage in a murine model of liver injury from alpha-1-antitrypsin deficiency.
    Rudnick DA; Shikapwashya O; Blomenkamp K; Teckman JH
    Hepatology; 2006 Oct; 44(4):976-82. PubMed ID: 17006946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autophagy induced by exogenous bile acids is therapeutic in a model of α-1-AT deficiency liver disease.
    Tang Y; Fickert P; Trauner M; Marcus N; Blomenkamp K; Teckman J
    Am J Physiol Gastrointest Liver Physiol; 2016 Jul; 311(1):G156-65. PubMed ID: 27102560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analyses of hepatocellular proliferation in a mouse model of alpha-1-antitrypsin deficiency.
    Rudnick DA; Liao Y; An JK; Muglia LJ; Perlmutter DH; Teckman JH
    Hepatology; 2004 Apr; 39(4):1048-55. PubMed ID: 15057909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative stress contributes to liver damage in a murine model of alpha-1-antitrypsin deficiency.
    Marcus NY; Blomenkamp K; Ahmad M; Teckman JH
    Exp Biol Med (Maywood); 2012 Oct; 237(10):1163-72. PubMed ID: 23104507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and histologic features of adults with alpha-1 antitrypsin deficiency in a non-cirrhotic cohort.
    Clark VC; Marek G; Liu C; Collinsworth A; Shuster J; Kurtz T; Nolte J; Brantly M
    J Hepatol; 2018 Dec; 69(6):1357-1364. PubMed ID: 30138687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-1 antitrypsin Z protein (PiZ) increases hepatic fibrosis in a murine model of cholestasis.
    Mencin A; Seki E; Osawa Y; Kodama Y; De Minicis S; Knowles M; Brenner DA
    Hepatology; 2007 Nov; 46(5):1443-52. PubMed ID: 17668872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-1 antitrypsin and liver disease: mechanisms of injury and novel interventions.
    Teckman JH; Mangalat N
    Expert Rev Gastroenterol Hepatol; 2015 Feb; 9(2):261-8. PubMed ID: 25066184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha-1-antitrypsin mutant Z protein content in individual hepatocytes correlates with cell death in a mouse model.
    Lindblad D; Blomenkamp K; Teckman J
    Hepatology; 2007 Oct; 46(4):1228-35. PubMed ID: 17886264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver Fibrosis and Metabolic Alterations in Adults With alpha-1-antitrypsin Deficiency Caused by the Pi*ZZ Mutation.
    Hamesch K; Mandorfer M; Pereira VM; Moeller LS; Pons M; Dolman GE; Reichert MC; Schneider CV; Woditsch V; Voss J; Lindhauer C; Fromme M; Spivak I; Guldiken N; Zhou B; Arslanow A; Schaefer B; Zoller H; Aigner E; Reiberger T; Wetzel M; Siegmund B; Simões C; Gaspar R; Maia L; Costa D; Bento-Miranda M; van Helden J; Yagmur E; Bzdok D; Stolk J; Gleiber W; Knipel V; Windisch W; Mahadeva R; Bals R; Koczulla R; Barrecheguren M; Miravitlles M; Janciauskiene S; Stickel F; Lammert F; Liberal R; Genesca J; Griffiths WJ; Trauner M; Krag A; Trautwein C; Strnad P;
    Gastroenterology; 2019 Sep; 157(3):705-719.e18. PubMed ID: 31121167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival Advantage of Both Human Hepatocyte Xenografts and Genome-Edited Hepatocytes for Treatment of α-1 Antitrypsin Deficiency.
    Borel F; Tang Q; Gernoux G; Greer C; Wang Z; Barzel A; Kay MA; Shultz LD; Greiner DL; Flotte TR; Brehm MA; Mueller C
    Mol Ther; 2017 Nov; 25(11):2477-2489. PubMed ID: 29032169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapamycin reduces intrahepatic alpha-1-antitrypsin mutant Z protein polymers and liver injury in a mouse model.
    Kaushal S; Annamali M; Blomenkamp K; Rudnick D; Halloran D; Brunt EM; Teckman JH
    Exp Biol Med (Maywood); 2010 Jun; 235(6):700-9. PubMed ID: 20511674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-1-antitrypsin deficiency: from genoma to liver disease. PiZ mouse as model for the development of liver pathology in human.
    Giovannoni I; Callea F; Stefanelli M; Mariani R; Santorelli FM; Francalanci P
    Liver Int; 2015 Jan; 35(1):198-206. PubMed ID: 24529185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of PGC1α Downstream of the Insulin Signaling Pathway Plays a Role in the Hepatic Proteotoxicity of Mutant α1-Antitrypsin Deficiency Variant Z.
    Rudnick DA; Huang J; Hidvegi T; Chu AS; Hale P; Munanairi A; Dietzen DJ; Cliften PF; Tycksen E; Lutkewitte AJ; Finck BN; Pak SC; Silverman GA; Perlmutter DH
    Gastroenterology; 2022 Jul; 163(1):270-284. PubMed ID: 35301011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accumulation of PiZ alpha 1-antitrypsin causes liver damage in transgenic mice.
    Carlson JA; Rogers BB; Sifers RN; Finegold MJ; Clift SM; DeMayo FJ; Bullock DW; Woo SL
    J Clin Invest; 1989 Apr; 83(4):1183-90. PubMed ID: 2784798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FBG1 Is the Final Arbitrator of A1AT-Z Degradation.
    Wen JH; Wen H; Gibson-Corley KN; Glenn KA
    PLoS One; 2015; 10(8):e0135591. PubMed ID: 26295339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An autophagy-enhancing drug promotes degradation of mutant alpha1-antitrypsin Z and reduces hepatic fibrosis.
    Hidvegi T; Ewing M; Hale P; Dippold C; Beckett C; Kemp C; Maurice N; Mukherjee A; Goldbach C; Watkins S; Michalopoulos G; Perlmutter DH
    Science; 2010 Jul; 329(5988):229-32. PubMed ID: 20522742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene transfer of master autophagy regulator TFEB results in clearance of toxic protein and correction of hepatic disease in alpha-1-anti-trypsin deficiency.
    Pastore N; Blomenkamp K; Annunziata F; Piccolo P; Mithbaokar P; Maria Sepe R; Vetrini F; Palmer D; Ng P; Polishchuk E; Iacobacci S; Polishchuk R; Teckman J; Ballabio A; Brunetti-Pierri N
    EMBO Mol Med; 2013 Mar; 5(3):397-412. PubMed ID: 23381957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Liver changes in heterozygote alpha 1-antitrypsin deficiency PiZ].
    Zhou H; Fischer HP
    Pathologe; 2000 Nov; 21(6):433-40. PubMed ID: 11148823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amelioration of Alpha-1 Antitrypsin Deficiency Diseases with Genome Editing in Transgenic Mice.
    Shen S; Sanchez ME; Blomenkamp K; Corcoran EM; Marco E; Yudkoff CJ; Jiang H; Teckman JH; Bumcrot D; Albright CF
    Hum Gene Ther; 2018 Aug; 29(8):861-873. PubMed ID: 29641323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.